For psoriasis, targeting skin protein may help control inflammation

When tested in mice, psoriasis became more severe when more interferon kappa was present.

12:55 PM

Author | Noah Fromson

woman holding her wrist
Getty Images

Results from a Michigan Medicine study reveal that targeting a protein found in the skin may reduce the severity of psoriasis.  

Interferons play a major role in activating the body's response to viral threats, but they have also been detected in the lesions of many psoriasis patients at abnormal levels. Psoriasis is an autoimmune disease that causes overproduction of skin cells and impacts nearly 30 million people in the world.

Using a model that mimics psoriasis in mice, researchers found that changing the levels of interferon kappa, a protein made by skin cells, altered the severity of inflammation and production of cell signaling molecules, called cytokines, that induce inflammation characteristic of psoriasis. Investigators found more psoriasis-like inflammation when more interferon kappa was present, while decreasing interferon kappa levels reduced disease.

Like Podcasts? Add the Michigan Medicine News Break on iTunes, Google Podcasts or anywhere you listen to podcasts.

The findings, published in the Journal of Investigative Dermatology, suggest using therapies to modulate interferon states may limit inflammation in psoriasis patients.

"We've known that psoriatic inflammation is marked by interferon-related gene expression, but how interferons alter the severity of the disease has not been clear," said J. Michelle Kahlenberg, M.D., Ph.D., associate professor of rheumatology at Michigan Medicine and senior author of the paper. "Understanding how interferon kappa may modulate psoriasis brings us one step closer to optimizing our treatments."

Understanding how interferon kappa may modulate psoriasis brings us one step closer to optimizing our treatments.
J. Michelle Kahlenberg, M.D., Ph.D.

The research team induced psoriasis in mouse models, splitting them into groups with interferon kappa at low, normal or elevated levels. The overexpressed protein alone didn't induce the disease, but it primed the skin for the inflammatory response that followed.  

"This work shows how the context of the skin environment can shape inflammatory responses." said Mehrnaz Gharaee-Kermani, DVM, M.P.H., Ph.D., lead author of the study and a senior research lab specialist at Michigan Medicine. "It will be exciting to see how this can be applied in clinic."

SEE ALSO: Genetic Prediction Model Helps Identify Arthritis Risk in Psoriasis Patients

The research team is conducting further studies to understand the role of interferon kappa in psoriasis patients through their Taubman Institute-sponsored study at Michigan Medicine and in partnership with Johann E. Gudhonsson, M.D., Ph.D., receiving funding through the National Psoriasis Foundation. Several treatments are used against the disease, but there is no cure.

A few current psoriasis drugs inhibit interferons, but many that are more specific are still in the trial phase. Coupled with the study's findings, personalized medicine will be paramount as physicians attempt to treat this disease, Kahlenberg said.

"Until now, treatments have been tested by studying a drug in hundreds of patients, lumping the average of them all together and targeting the average of those patients," Kahlenberg said. "As any patient who has been on these medications will tell you, this trial–and-error approach wastes patient time and money trying to get control of the disease. Understanding a patient's background level of interferon might help us target things within that person to make their disease better faster and stay in remission."

MORE FROM THE LAB: Subscribe to our weekly newsletter

Paper cited: "Interferon Kappa is a Rheostat for Development of Psoriasiform Inflammation," Journal of Investigative Dermatology. DOI: 0.1016/j.jid.2021.05.029


More Articles About: Lab Report Psoriasis All Research Topics Skin Conditions
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories purple cells floating up close
Health Lab
Study links gene network and pancreatic beta cell defects to type 2 diabetes
Teams from Vanderbilt University Medical Center and the University of Michigan design a comprehensive study that integrates multiple analytic approaches that has linked a regulatory gene network and functional defects in insulin-producing pancreatic beta cells to type 2 diabetes.
smart watch on wrist
Health Lab
Clinical smart watch finds success at identifying atrial fibrillation
A Michigan Medicine research team developed a prescription wristwatch that continuously monitors the wearer’s heart rhythm and uses a unique algorithm to detect atrial fibrillation. The clinical-grade device, called the Verily Study Watch, proved very accurate at identifying atrial fibrillation in participants.
sketched out bacteria in a dish yellow and blue colors of U-M
Health Lab
This gross mixture has big benefits for the study of bacteria
Michigan Medicine researchers have found that growing bacteria on agar mixed with organs is an efficient and effective way to study infectious pathogens.
green blue map of michigan
Health Lab
How does exposure to ‘forever chemicals’ impact your cancer risk
Pearce, professor of epidemiology at the School of Public Health and co-lead of Rogel’s cancer control and population sciences program, reflects on the project and why bringing this study to Michigan is so critical.
person holding walker with nurse next to them closer up on hands lower body
Health Lab
Long COVID happens in nursing homes, too
Post-acute sequelae of Sars-COV2 (PASC, long COVID) caused a decrease in independence and cognitive ability after coronavirus infection in nursing home residents
expert at stand hearing in suit
Health Lab
Keep telehealth alive and well, experts tell Senate subcommittee
Telehealth coverage by Medicare is scheduled to expire at the end of 2024; experts told Senators what they think should happen to preserve it.